🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this research is to measure certain indicators of resilien...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-09-28
Trial ID
NCT04188678
Treatments Being Tested
The purpose of this pivotal study is to determine if intravenous Rezafungin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-11
Trial ID
NCT04368559
If transplantation using mismatched unrelated donors or non-first-degree re...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2010-09
Trial ID
NCT01203722
Background: * One way to treat certain cancers of the blood and immune sys...
Status
Completed
Location
Childrens National Medical Center
Start Date
2011-04-19
Trial ID
NCT01338987
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-06-23
Trial ID
NCT00489281
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Terminated
Location
University of Alabama Comprehensive Cancer Center
Start Date
1995-10
Trial ID
NCT00002961
This research is being done to learn more about reduced-intensity bone marr...
Status
Terminated
Location
The Sydney Kimmel Comprehensive Cancer Center
Start Date
2010-08
Trial ID
NCT01135329
Treatments Being Tested
Atorvastatin for prevention of acute GVHD...
Status
Completed
Location
West Virginia University Hospitals Mary Babb Randolph Cancer Center
Start Date
2010-07
Trial ID
NCT01175148
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as cytarabine and mitoxantrone, ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
1999-06
Trial ID
NCT00609739
The protocol is a phase I open label study evaluating the safety and feasib...
Status
Terminated
Location
Children's Healthcare of Atlanta at Egleston
Start Date
2021-12-02
Trial ID
NCT04328714
Treatments Being Tested